Interpretation of the evidence for the efficacy and safety of statin therapy

This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet (British edition) Ročník 388; číslo 10059; s. 2532 - 2561
Hlavní autori:	Collins, Rory, Reith, Christina, Emberson, Jonathan, Armitage, Jane, Baigent, Colin, Blackwell, Lisa, Blumenthal, Roger, Danesh, John, Smith, George Davey, DeMets, David, Evans, Stephen, Law, Malcolm, MacMahon, Stephen, Martin, Seth, Neal, Bruce, Poulter, Neil, Preiss, David, Ridker, Paul, Roberts, Ian, Rodgers, Anthony, Sandercock, Peter, Schulz, Kenneth, Sever, Peter, Simes, John, Smeeth, Liam, Wald, Nicholas, Yusuf, Salim, Peto, Richard
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Ltd 19.11.2016 Elsevier Limited
Predmet:	Anticholesteremic Agents - therapeutic use Cardiovascular disease Cholesterol Cholesterol, LDL - blood Clinical outcomes Clinical Trials as Topic Coronary Disease - drug therapy Coronary Disease - prevention & control Drug therapy Drug-Related Side Effects and Adverse Reactions Health risks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Internal Medicine Myocardial Infarction - drug therapy Myocardial Infarction - prevention & control Pain Patient safety Patients Prevention Risk Assessment Safety Side effects Simvastatin - therapeutic use Statins Stroke - drug therapy Stroke - prevention & control Studies Vascular diseases
ISSN:	0140-6736, 1474-547X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!